Labcorp Income Statement
LH / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Labcorp reported $14.0B in revenue and $877M in net income for FY2025. Revenue has grown at a 6.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.0B | $13.0B | $12.2B | $11.9B | $13.1B | $11.3B | $11.6B | $11.3B | $10.3B | $9.6B | $8.7B | $6.0B | $5.8B | $5.7B | $5.5B |
| Cost of Revenue | $9.9B | $9.4B | $8.8B | $8.2B | $8.1B | $8.2B | $8.3B | $8.2B | $6.7B | $6.3B | $5.6B | $3.8B | $3.6B | $3.4B | $3.3B |
| Gross Profit | $4.0B | $3.6B | $3.4B | $3.7B | $5.0B | $3.2B | $3.3B | $3.2B | $3.1B | $2.9B | $2.9B | $516.8M | $2.2B | $2.2B | $2.3B |
| SG&A Expense | $2.2B | $2.2B | $2.0B | $1.8B | $1.7B | $1.6B | $1.6B | $1.6B | $1.5B | $1.3B | $1.6B | $1.2B | $1.1B | $1.1B | $1.2B |
| Operating Income | $1.4B | $1.1B | $725.6M | $1.4B | $3.0B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $996.8M | $910.4M | $990.9M | $1.0B | $948.4M |
| Interest Expense | $224.1M | $208.3M | $199.6M | $179.8M | $211.8M | $244.2M | $240.7M | $244.2M | $235.1M | $219.1M | $274.9M | $109.5M | $96.5M | $94.5M | $87.5M |
| Income Tax | $229.8M | $212.4M | $188.5M | $233.9M | $690.0M | $384.4M | $280.0M | $384.4M | -$155.4M | $360.7M | $287.3M | $314.1M | $340.2M | $359.4M | $333.0M |
| Net Income | $876.5M | $746.0M | $418.0M | $1.3B | $2.4B | $883.7M | $823.8M | $883.7M | $1.2B | $711.8M | $437.6M | $113.1M | $573.8M | $583.1M | $519.7M |
| EPS (Basic) | $4.80 | $14.05 | $24.60 | $14.05 | $15.99 | $8.71 | $11.99 | $6.94 | $4.43 | $4.43 | $6.36 | $6.09 | $5.20 | $5.42 | $5.06 |
| EPS (Diluted) | $4.77 | $13.97 | $24.39 | $13.97 | $15.88 | $8.61 | $11.81 | $6.82 | $4.35 | $4.35 | $6.25 | $5.99 | $5.11 | $5.29 | $4.98 |
| Shares Outstanding | 88.2M | 93.1M | 97.5M | 91.6M | 98.0M | 102.6M | 98.9M | 101.9M | 102.7M | 101.3M | 84.6M | 85.7M | 93.5M | 97.8M | 102.4M |
| Gross Margin | 28.8% | 27.9% | 27.7% | 31.3% | 38.0% | 28.0% | 28.1% | 28.0% | 30.0% | 29.9% | 33.5% | 8.6% | 38.3% | 39.7% | 41.0% |
| Operating Margin | 9.9% | 8.3% | 6.0% | 12.1% | 23.2% | 11.7% | 11.5% | 11.7% | 12.7% | 13.3% | 11.5% | 15.1% | 17.1% | 18.1% | 17.1% |
| Profit Margin | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% | 7.8% | 7.1% | 7.8% | 11.9% | 7.4% | 5.0% | 1.9% | 9.9% | 10.3% | 9.4% |